Overview

A Single Ascending Dose Study of AV-006 in Healthy Subjects

Status:
Unknown status
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
Characterization of the single dose pharmacokinetics of AV-006 in healthy male and female subjects. Description of safety and tolerability of AV-006 in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Arixa Pharmaceuticals